admin

Neuro2Go Offers Sampled Alzheimer’s Risk Test

Neuro2Go offers a convenient way to talk to a board-certified neurologist, which will now provide the Sampled Alzheimer’s Risk Test, to assess the genetic risk of cognitive decline due to Alzheimer’s disease. The test uses Cytox’s genoSCORE technology to generate a comprehensive genetic analysis for the risk of Alzheimer’s disease from a simple saliva sample. …

Neuro2Go Offers Sampled Alzheimer’s Risk Test Read More »

FDA Approves Vaccine While Doctors Urge Community to Get Vaccinated

On August 23, the U.S. Food and Drug Administration (FDA) approved the Pfizer-BioNTech COVID-19 Vaccine. The vaccine will now be marketed as Comirnaty for the prevention of COVID-19 disease in individuals 16 and older. It is also available under emergency use authorization (EUA), for individuals 12-15 years old. On the same day, a news conference …

FDA Approves Vaccine While Doctors Urge Community to Get Vaccinated Read More »

The First Florida Patient to Receive Biogen’s Aduhelm for Alzheimer’s Disease

Jeffrey Gelblum, MD, a board-certified neurologist with First Choice Neurology and Neuro2Go, the nation’s largest neurology practice, treated the first patient in Florida with Biogen’s Aduhelm (aducanumab), an infusion treatment for early-stage Alzheimer’s patients. Aduhelm decreases amyloid plaque in the brain, which is a marker for Alzheimer’s disease. Florida’s first Aduhelm patient is a middle-aged …

The First Florida Patient to Receive Biogen’s Aduhelm for Alzheimer’s Disease Read More »

Translate »
Scroll to Top